Cancer News and Research

Latest Cancer News and Research

Study: Investigational drug shows promise against pancreatic cancer

An investigational drug that disrupts tumor blood vessels shows promise against a rare type of pancreatic cancer, scientists at Albert Einstein College of Medicine of Yeshiva University have found. Their results were presented October 20 during a poster session at an international cancer conference.

25 Oct 2013

Study identifies gene that raises risk for colorectal cancer from eating red or processed meat

A common genetic variant that affects 1 in 3 people significantly increases the risk of colorectal cancer from the consumption of red meat and processed meat, according to a study presented today at the annual American Society of Human Genetics 2013 meeting, the largest gathering of human geneticists in the world.

25 Oct 2013

Canadian Partnership Against Cancer, Heart and Stroke Foundation to improve health of Canadians

The Canadian Partnership Against Cancer and the Heart and Stroke Foundation, are pleased to announce a $16 million investment in a first of its kind partnership between the cancer and cardiovascular research communities that will strengthen our understanding of chronic disease.

24 Oct 2013

HM Hospitales expects to treat first patients with Elekta's Versa HD system in 2015

HM Hospitales, a private hospital group in Spain, anticipates treating its first patients with Elekta's Versa HD™ system in 2015. Versa HD, to be sited in the group's sixth hospital, is an advanced radiation treatment system designed to enhance the management of cancer care and treat a broad spectrum of tumors throughout the body.

From Elekta 24 Oct 2013

Viewpoints: 'Elementary errors' in insurance exchange; problems could lead insurance pool imbalance; recalcitrant govs could have made Obamacare launch better

Clearly, the government picked the wrong people to manage this project and it was a terrible decision to fragment it among so many contractors. Anyone who's ever been involved in creating a new computer application knows that you don't just assemble the thing and then see if it works. You're supposed to test the components, obsessively, along the way (Andrew Rosenthal, 10/22).

24 Oct 2013

Study reveals that tumors factors inhibit repair of damaged muscle fibers during cancer wasting

A new study reveals that tumors release factors into the bloodstream that inhibit the repair of damaged muscle fibers, and that this contributes to muscle loss during cancer wasting.

24 Oct 2013

New Centre for Stratified Medicine opened in Ireland

The University of Ulster has opened a new Centre for Stratified Medicine. The only Centre of its kind in Ireland, £11.5m research facility in Derry~Londonderry puts the University at the forefront of medical research into chronic degenerative diseases.

24 Oct 2013

Thomas Jefferson University’s interactive program discusses pros and cons of prostate cancer treatment

When the pros and cons of prostate cancer treatment are spelled out using an online interactive program developed by Thomas Jefferson University researchers, more patients choose active surveillance over therapy, according to research being presented Wednesday (October 23rd) at the Society for Medical Decision Making annual meeting in Baltimore, Maryland.

24 Oct 2013

Scientists find disparities in regulation of transposons between humans and non-human primate cells

Researchers at the Salk Institute for Biological Studies have, for the first time, taken chimpanzee and bonobo skin cells and turned them into induced pluripotent stem cells, a type of cell that has the ability to form any other cell or tissue in the body.

24 Oct 2013

Leukemia drug reverses symptoms of colitis in lab tests

A drug currently on the market to treat leukemia reversed symptoms of colitis in lab tests, according to recently published findings by medical researchers with the University of Alberta.

24 Oct 2013

MEDIAN Technologies announces participation in World Conference on Lung Cancer

MEDIAN Technologies, a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials and clinical routine, today announced its participation in the World Conference on Lung Cancer, to be held October 27-30, in Sydney, Australia.

24 Oct 2013

FDA to phase out all inhaler medical products containing CFCs by Dec. 31

The U.S. Food and Drug Administration will complete its phase-out of all inhaler medical products containing chlorofluorocarbons by Dec. 31, 2013. This effort is to comply with an international treaty to protect the ozone layer by phasing out the worldwide production of numerous substances, including CFCs, which contribute to ozone depletion.

24 Oct 2013

Patient assistance programs help breast cancer patients to learn more about adjuvant therapy

Patient assistance programs can help breast cancer patients meet a variety of needs that can interfere with getting recommended adjuvant therapies such as radiation, chemotherapy, and hormonal treatments, according to a study published recently in the online edition of the Journal of Oncology Practice.

24 Oct 2013

Nanometric scale diamond particles offer new way to detect cancer far earlier

Real-time monitoring of cancer cell processes could soon be possible thanks to nanometric scale diamonds used as biosensors.

24 Oct 2013

Activation mechanism of protective protein in ocular lens resolved

The lens of the human eye is made up of a highly concentrated protein solution that imparts the eye its high refractive power. Yet, despite this high protein content the ocular lens must remain clear and transparent.

24 Oct 2013

Diffregen awarded SBIR Phase 1 grant to advance Angiocidin towards human clinical trials

Diffregen LLC, a Temple University startup company, has been awarded a small business innovation research Phase 1 grant by the National Cancer Institute to advance Angiocidin, a university-created therapeutic to treat acute myeloid leukemia, to the doorstep of human clinical trials.

24 Oct 2013

Metformin could serve as radiosensitizer to treat patients with stage III non-small cell lung cancer

Treating aggressive lung cancer with the diabetes drug metformin along with radiation and chemotherapy may slow tumor growth and recurrence, suggests new preliminary findings from researchers at the Perelman School of Medicine at the University of Pennsylvania being presented during an oral abstract session October 28 at the 15th World Conference on Lung Cancer.

24 Oct 2013

Study: Youth obesity associated with receptiveness to TV fast food advertising

Youth obesity is associated with receptiveness to TV fast food advertising, Norris Cotton Cancer Center researchers found in a study published in the November issue of the American Journal of Preventive Medicine.

24 Oct 2013

Study uncovers new genetic pathways that could revolutionise acute dendritic leukaemia treatment

Acute dendritic leukaemia is a rare type of leukaemia, but one with the worst prognosis-the average patient survival rate is just 12-14 months-that is difficult to treat. Juan Cruz Cigudosa's team, from the Spanish National Cancer Research Centre's Molecular Cytogenetics Group, has for the first time sequenced the exome -the coding, or protein-generating, regions of the genome- of dendritic cell leukaemia.

24 Oct 2013

Researchers improve cytostatic therapy for children with chronic immune deficiency disorder

Researchers at Karolinska Institutet in Sweden, and colleagues at University Children's Hospital Z-rich in Switzerland have managed to improve cytostatic therapy for children with the chronic immune deficiency disorder granulomatous disease prior to stem cell transplantation.

24 Oct 2013

Cancer News and Research

Latest Cancer News and Research

Study: Investigational drug shows promise against pancreatic cancer

Study identifies gene that raises risk for colorectal cancer from eating red or processed meat

Canadian Partnership Against Cancer, Heart and Stroke Foundation to improve health of Canadians

HM Hospitales expects to treat first patients with Elekta's Versa HD system in 2015

Viewpoints: 'Elementary errors' in insurance exchange; problems could lead insurance pool imbalance; recalcitrant govs could have made Obamacare launch better

Study reveals that tumors factors inhibit repair of damaged muscle fibers during cancer wasting

New Centre for Stratified Medicine opened in Ireland

Thomas Jefferson University’s interactive program discusses pros and cons of prostate cancer treatment

Scientists find disparities in regulation of transposons between humans and non-human primate cells

Leukemia drug reverses symptoms of colitis in lab tests

MEDIAN Technologies announces participation in World Conference on Lung Cancer

FDA to phase out all inhaler medical products containing CFCs by Dec. 31

Patient assistance programs help breast cancer patients to learn more about adjuvant therapy

Nanometric scale diamond particles offer new way to detect cancer far earlier

Activation mechanism of protective protein in ocular lens resolved

Diffregen awarded SBIR Phase 1 grant to advance Angiocidin towards human clinical trials

Metformin could serve as radiosensitizer to treat patients with stage III non-small cell lung cancer

Study: Youth obesity associated with receptiveness to TV fast food advertising

Study uncovers new genetic pathways that could revolutionise acute dendritic leukaemia treatment

Researchers improve cytostatic therapy for children with chronic immune deficiency disorder

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Newsletters you may be interested in